Corticobasal syndrome (CBS) is clinically characterized by progressive asymmetric rigidity and apraxia together with symptoms suggestive of cortical involvement and basal ganglia dysfunction. The spectrum of neurodegenerative diseases that can manifest with CBS is wide. The associations of CBS with corticobasal degeneration, progressive supranuclear palsy, Alzheimer's disease, frontotemporal lobar degenerations, Creutzfeldt-Jakob disease, or diffuse Lewy body pathology have been reported. We describe the case of a 71-year-old woman with CBS. The histopathological examination of brain tissue revealed concomitant pathology corresponding to the limbic stage of Lewy-related pathology and the intermediate stage of Alzheimer's-type pathology. To date, there have been only a few cases with a similar combination of pathology manifesting with the CBS phenotype that have been described in the literature. The extent and distribution of pathological changes in these cases were somewhat different from ours, and significance for clinical manifestation was attributed to only one of these pathologies. In our case, we assume that both types of pathology contributed to the development of the disease, considering the presumed specific spread of both types of pathological processes according to Braak's staging. Our case expands the spectrum of neurodegenerative pathological processes that may manifest with the typical CBS phenotype. Also, it points out the importance of identifying specific biomarkers that would enable more accurate in vivo differential diagnosis and more accurate determination of the underlying pathological processes of these diseases.

Department of Clinical and Molecular Pathology University Hospital Palacky University Olomouc Czechia

Department of Neurology Faculty of Medicine and Dentistry Palacky University Olomouc Czechia

Department of Neurology University Hospital Palacky University Olomouc Czechia

Zobrazit více v PubMed

Armstrong M. J., Litvan I., Lang A. E., Bak T. H., Bhatia K. P., Borroni B., et al. . (2013). Criteria for the diagnosis of corticobasal degeneration. Neurology 80, 496–503. 10.1212/WNL.0b013e31827f0fd1 PubMed DOI PMC

Boeve B. F. (2011). The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study. J. Mol. Neurosci. 45, 350–353. 10.1007/s12031-011-9624-1 PubMed DOI

Braak H., Braak E. (1995). Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 16, 271–284. 10.1016/0197-4580(95)00021-6 PubMed DOI

Braak H., Del Tredici K., Rüb U., de Vos R. A. I., Jansen Steur E. N., Braak E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197–211. 10.1016/S0197-4580(02)00065-9 PubMed DOI

Casseron W., Azulay J. P., Guedj E., Gastaut J. L., Pouget J. (2005). Familial autosomal dominant corticobasal degeneration with the P301S mutation in the tau gene: an example of phenotype variability. J. Neurol. 252, 1546–1548. 10.1007/s00415-005-0880-2 PubMed DOI

Day G. S., Lim T. S., Hassenstab J., Goate A. M., Grant E. A., Roe C. M., et al. . (2017). Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer's disease. Neurology 88, 1273–1281. 10.1212/WNL.0000000000003770 PubMed DOI PMC

Della Sala S., Lucchelli F., Spinnier H. (1987). Ideomotor apraxia in patients with dementia of Alzheimer type. J. Neurol. 234, 91–93. 10.1007/BF00314108 PubMed DOI

Giannakopoulos P., Duc M., Gold G., Hof P. R., Michel J. P., Bouras C. (1998). Pathologic correlates of apraxia in Alzheimer disease. Arch. Neurol. 55, 689–695. 10.1001/archneur.55.5.689 PubMed DOI

Golaz J., Bouras C., Hof P. R. (1992). Motor cortex involvement in presenile dementia: report of a case. J. Geriatr. Psychiatry Neurol. 5, 85–92. 10.1177/002383099200500205 PubMed DOI

Greene J. D. W., Patterson K., Xuereb J., Hodges J. R. (1996). Alzheimer Disease and non-fluent Progressive Aphasia. Arch. Neurol. 53, 1072–1078. 10.1001/archneur.1996.00550100158027 PubMed DOI

Gross R. G., Grossman M. (2008). Update on apraxia. Curr. Neurol. Neurosci. Rep. 8, 490–496. 10.1007/s11910-008-0078-y PubMed DOI PMC

Hauser W. A., Morris M. L., Heston L. L., Anderson V. E. (1986). Seizures and myoclonus in patients with Alzheimer's disease. Neurology 36, 1226–1230. 10.1212/WNL.36.9.1226 PubMed DOI

Horoupian D. S., Wasserstein P. H. (1999). Alzheimer's disease pathology in motor cortex in dementia with Lewy bodies clinically mimicking corticobasal degeneration. Acta Neuropathol. 98, 317–322. 10.1007/s004010051087 PubMed DOI

Imamura A., Wszolek Z. K., Lucas J. A., Dickson D. W. (2009). Corticobasal syndrome with Alzheimer's disease pathology. Mov. Disord. 24, 152–153. 10.1002/mds.21877 PubMed DOI

Irwin D. J., Trojanowski J. Q., Grossman M. (2013). Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease. Front. Aging Neurosci. 5:6. 10.3389/fnagi.2013.00006 PubMed DOI PMC

Jagust W. J., Davies P., Tiller-Borcich J. K., Reed B. R. (1990). Focal Alzheimer's disease. Neurology 40, 14–19. 10.1212/WNL.40.1.14 PubMed DOI

Kasanuki K., Josephs K. A., Ferman T. J., Murray M. E., Koga S., Konno T., et al. . (2018). Diffuse Lewy body disease manifesting as corticobasal syndrome. A rare form of Lewy body disease. Neurology 91:e279. 10.1212/WNL.0000000000005828 PubMed DOI PMC

Kertesz A., McMonagle P. (2010). Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy. J. Neurol. Sci. 289, 138–143. 10.1016/j.jns.2009.08.036 PubMed DOI

Ling H., O'Sullivan S. S., Holton J. L., Revesz T., Massey L. A., Williams D. R., et al. . (2010). Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 133, 2045–2057. 10.1093/brain/awq123 PubMed DOI

Machado de Oliveira L., Barcellos I., Teive H. A. G., Munhoz R. P. (2017). Cognitive dysfunction in corticobasal degeneration. Arq. Neuropsiquiatr. 75, 570–579. 10.1590/0004-282x20170077 PubMed DOI

Massman P. J., Kreiter K. T., Jankovic J., Doody R. S. (1996). Neuropsychological functioning in cortical-basal ganglionic degeneration: differentiation from Alzheimer's disease. Neurology 46, 720–726. 10.1212/WNL.46.3.720 PubMed DOI

Mathew R., Bak T. H., Hodges J. R. (2012). Diagnostic criteria for corticobasal syndrome: a comparative study. J. Neurol. Neurosurg. Psychiatry 83, 405–410. 10.1136/jnnp-2011-300875 PubMed DOI

McKeith I. G., Galasko D., Kosaka K., Perry E. K., Dickson D. W., Hansen L. A., et al. . (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47, 1113–1124. 10.1212/WNL.47.5.1113 PubMed DOI

Mendez M. F. (2019). Early-onset Alzheimer disease and its variants. Continuum 25, 34–51. 10.1212/CON.0000000000000687 PubMed DOI PMC

Mirra S., Heyman A., McKeel D., Sumi S., Crain B., Broxnlee L., et al. . (1991). The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 40, 479–486. 10.1212/WNL.41.4.479 PubMed DOI

Montine T. J., Phelps C. H., Beach T. G., Bigio E. H., Cairns N. J., Dickson D. W., et al. . (2012). National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 123, 1–11. 10.1007/s00401-011-0910-3 PubMed DOI PMC

Nielson K. A., Cummings B. J., Cotman C. W. (1996). Constructional apraxia in Alzheimer's disease correlates with neuritic neuropathology in occipital cortex. Brain Res. 741, 284–293. 10.1016/S0006-8993(96)00983-3 PubMed DOI

Nishida H., Hayashi Y., Harada N., Sakurai T., Wakida K. (2019). Mixed Alzheimer's and Lewy-related pathology can cause corticobasal syndrome with visual hallucinations. Intern. Med. 58:1815. 10.2169/internalmedicine.2496-18 PubMed DOI PMC

Pardini M., Huey E. D., Cavanagh A. L., Grafman J. (2009). Olfactory function in corticobasal syndrome and frontotemporal dementia. Arch. Neurol. 66, 92–96. 10.1001/archneurol.2008.521 PubMed DOI PMC

Pillon B., Blin J., Vidailhet M., Deweer B., Sirigu A., Dubois B., et al. . (1995). The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 45, 1477–1483. 10.1212/WNL.45.8.1477 PubMed DOI

Přikrylova-Vranova H., Henykova E., Kaiserova M., Mensikova K., Vastik M., Mares J., et al. . (2014). Tau protein, beta-amyloid1-42, and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia. J. Neurol. Sci. 343, 120–124. 10.1016/j.jns.2014.05.052 PubMed DOI

Rapcsak S. Z., Ochipa C., Anderson K. C., Polzner H. (1995). Progressive ideomotor apraxia: evidence for a selective impairment of the action production system. Brain Cogn. 27, 2013–2036. 10.1006/brcg.1995.1018 PubMed DOI

Riley D. E., Lang A. E., Lewis A., Resch L., Ashby P., Hornykiewicz O., et al. . (1990). Cortical-basal ganglionic degeneration. Neurology 40, 1203–1212. 10.1212/WNL.40.8.1203 PubMed DOI

Rinne J. O., Lee M. S., Thompson P. D., Marsden C. D. (1994). Corticobasal degeneration: a clinical study of 36 cases. Brain 117, 1183–1196. 10.1093/brain/117.5.1183 PubMed DOI

Rogalski E., Sridhar J., Rader B., Martersteck A., Chen K., Cobia D., et al. . (2016). Aphasic variant of Alzheimer disease: clinical, anatomic and genetic features. Neurology 87, 1337–1343. 10.1212/WNL.0000000000003165 PubMed DOI PMC

Saranza G. M., Whitwell J. L., Kovacs G. G., Lang A. E. (2019). Corticobasal degeneration. Int. Rev. Neurobiol. 149, 87–136. 10.1016/bs.irn.2019.10.014 PubMed DOI

Tartaglia M. C., Sidhu M., Laluz V., Racine C., Rabinovici G. D., Creighton K., et al. . (2010). Sporadic corticobasal syndrome due to FTLD-TDP. Acta Neuropathol. 119, 365–374. 10.1007/s00401-009-0605-1 PubMed DOI PMC

Tsuboi Y., Josephs K. A., Boeve B. F., Litvan I., Caselli R. J., Caviness J. N., et al. . (2005). Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov. Disord. 20, 982–988. 10.1002/mds.20478 PubMed DOI

Vandenberghe W., Sciot R., Demaerel P., Van Laere K. (2007). Sparing of the substantia nigra in sporadic Creutzfeldt-Jakob disease presenting as an acute corticobasal syndrome. Mov. Disord. 22, 1668–1669. 10.1002/mds.21570 PubMed DOI